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Prostate cancer incidence is steadily increasing in many developed countries. Because insular populations present unique ethnic,
geographical, and environmental characteristics, we analyzed the evolution of prostate cancer age-adjusted world standardized
incidence rates in Martinique in comparison with that of metropolitan France. We also compared prostate cancer incidence
rates, and lifestyle-related and socioeconomic markers such as life expectancy, dietary energy, and fat supply and consumption,
with those in other Caribbean islands, France, UK, Sweden, and USA. The incidence rate of prostate cancer in Martinique is
one of the highest reported worldwide; it is continuously growing since 1985 in an exponential mode, and despite a similar
screening detection process and lifestyle-related behaviour, it is constantly at a higher level than in metropolitan France. However,
Caribbean populations that are genetically close to that of Martinique have generally much lower incidence of prostate cancer.
We found no correlation between prostate cancer incidence rates, life expectancy, and diet westernization. Since the Caribbean
African descent-associated genetic susceptibility factor would have remained constant during the 1980–2005, we suggest that in
Martiniquesomeenvironmentalchangeincludingtheintensiveuseofcarcinogenicorganochlorinepesticidesmighthaveoccurred
as key determinant of the persisting highly growing incidence of prostate cancer.
1.Introduction
Prostate cancer incidence is steadily increasing in many de-
velopedcountries,whereitiscommonlyattributedtoimpro-
vement in screening detection and to population ageing [1].
Wehavepreviouslyanalysedthesetwofactors[2],andinres-
ponse to a recent article [3], we have argued that overdiagno-
sis by the routine use of prostate-speciﬁc antigen (PSA) test
cannot fully account for the growing incidence of this cancer
[4].Furthermore,increaseinlifeexpectancydoesnotexplain
whyoveralltheriseofcancerincidenceaﬀectsallagecategor-
ies [5] and why it occurs earlier in life [6].
In a previous multifactorial study, we have suggested that
in the two French Caribbean islands, Martinique and Guad-
eloupe,prostatecancermayinfactbecausedbyenvironmen-
tal factors and that among these factors, carcinogenic organ-
ochlorine pesticides may play a role [7].
In this paper, we further attempt to show that in Marti-
nique, environmental change may account for the growing
incidence of prostate cancer in highly susceptible people and
discuss the role of exogenous carcinogens that may be in-
volved.
2.MaterialandMethods
Because insular populations present unique ethnic, geo-
graphical,andenvironmentalcharacteristicsthatmaybewell
conserved, studies of populations of the Caribbean can help
elucidatetheaetiologyofprostatecancer.Wehavechosenthe
tropical island Martinique, in the French West Indies, be-
cause of its limited territory (1128km2), its low number of
inhabitants(414516),amedicalpracticeandlifestyle-related
behaviour that does not diﬀer from metropolitan France,2 Prostate Cancer
the availability of a cancer registry rigorously collecting and
reporting cases, and the possibility of determining environ-
ment- and lifestyle-related factors and their time-related
modiﬁcations.
Inthisecologicalstudy,wehaveanalysedtheevolutionof
prostate cancer incidence rates in Martinique in comparison
with that in metropolitan France during the period 1980–
2005andhavecomparedtheincidenceratesobtainedin2005
with those of other Caribbean islands and of UK, Sweden,
and USA. Data collection was done as follows: for Martini-
que, we used data from the Martinique cancer registry held
by AMREC, the Martinique Association for Epidemiological
Research on Cancer [8]. For comparison with metropolitan
France, we used data from the French National Sanitary Sur-
veillance Institute (InVS) [9], which provides incidence rates
from 11 metropolitan “department” registries. These registr-
ies are those from which the national extrapolated incidence
rates of prostate cancer in metropolitan France are based on.
For international comparison, we used incidence rates from
the Globocan 2008 database of the international Agency for
Research on Cancer (IARC) [10]. However, since these data
mayhavebeenhighlyextrapolated,wealsousedforcompari-
son data collected by speciﬁc registries including the one of
the public health ministry of Cuba [11], for UK, that is, for
England, Scotland, and Wales, those from the Oﬃce for Na-
tional Statistics [12], the Information Services Division,
Scotland[13],andtheWelshCancerIntelligenceandSurveil-
lance Unit [14], and for Sweden, USA, and metropolitan
France, those from the National Board of Health and Welfare
[15],theNationalCancerInstitute’sSurveillance,Epidemiol-
ogy and End Results (SEER) [16], and the InVS [9], respect-
ively.Finally,inordertomakedatacomparison,weonlycon-
sidered incidence rates that had been age-adjusted to the
IARCworldstandardandexpressedasage-standardizedrates
(ASR). Since in Martinique PSA screening does not diﬀer
frommetropolitan France,data processing consistedof com-
paring the evolution of prostate cancer incidence rates in
Martinique with that of metropolitan France. Furthermore,
inordertodeterminethebestmodelﬁttingincidencegrowth
curves, we checked for growth homogeneity for each of the
11 metropolitan French “department” registries and for the
registry of Martinique. For modeling, we used a least-square
regression analysis and established curve equations accord-
ing to the best values obtained for the determination coeﬃ-
cient R2. Since the best model ﬁts in exponential functions,
data were linearized by log transformation. For comparison
of the two groups, the interaction between group and time
was analyzed by a mixed linear model, assuming an unstruc-
tured covariance matrix for the random eﬀects and a ﬁrst-
order autoregression covariance structure for the within
population correlation. Slopes were treated as random eﬀect,
thus the intercept at year 1985 is interpretable as initiation of
growth, and the slope is interpretable as rate of growth for
each population. Mathematical treatments were done using
contrasts of ﬁxed eﬀects for the group slopes with inference
based on the F-test. Estimation by restricted maximum like-
lihood (REML) was computed using SPSS v.16.0 (SPSS, Inc.,
Chicago, Ill, USA), and model suitability was assessed by
Akaike’s information criterion. Coeﬃcients, conﬁdence
intervals (CI) of coeﬃcients, and two-sided P values are re-
ported for the model. Since it has been shown that due to
some ethnographic genetic factor, there is a marked increase
in prostate cancer incidence in African descents and because
Caribbean people are African descents, for international
comparison, we took into account the percentage of African
descents in Caribbean, UK, and Sweden in the Encyclopedia
oftheNations[17],theOﬃcebyNationalStatistics[18],and
theBefolkningsstatistik[19],respectively.Unfortunately,due
to legal regulation, data were not available for metropolitan
France, but a common estimation is that this percentage is
low and supposed to be not diﬀerent from the percentage in
UKandSweden.WealsoconsideredareportfromtheFrench
ministry of health indicating that the health care system in
Martinique and Guadeloupe does not diﬀer to that in metro-
politan France [20]. In addition, we used several usual-
lyacceptedsocioeconomicmarkersoflifestyle-relatedbehav-
iour, such as life expectancy at birth and food supply and
consumption in order to make comparison. For comparing
life expectancy at birth, we used data source from the WHO
Core Health Indicators database for 2006 [21], and for com-
paring dietary energy and fat supply and dietary energy and
fatconsumption,weuseddatasourcefromFAOFoodBalan-
ce Sheets 1988–1990 [22] and data source from FAO Statis-
ticalYearbook2009[23],respectively.Wealsouseddatafrom
Eurostat [24] and from US-EPA [25] for pesticide use and
exposure in the diﬀerent countries or territories analyzed for
which speciﬁc incidence registries were available. For Marti-
nique, we used the determination we had previously made
[7]. For determination of the correlation coeﬃcient, r,w e
used the Spearman test.
3. Results
Tables 1and2andFigures1and2summarizeourdata.Asin-
dicated in Table 1, the world age-standardized incidence rate
of prostate cancer in 2005 in Martinique is one of the highest
worldwide whatever it has been determined from the Marti-
nique speciﬁc registry of AMREC or estimated from the
IARC Globocan 2008 database: 177 per 100 000 according to
the AMREC registry and 173.7 per 100.000 according to the
IARC Globocan database. This incidence rate is indeed high-
er than those obtained from speciﬁc registries for metropoli-
tanFrance,Sweden,andUSAandmuchhigherthantheones
reported for UK. However, surprisingly, despite the fact that
with the exception of Cuba and Trinidad and Tobago, 80 to
95 percents of the Caribbean population are of African ori-
gin, as it is the case in Martinique, this incidence rate was
found to be much higher than those reported by IARC in
the Globocan 2008 database for Guadeloupe and other Cari-
bbeanislandsandevenhigherthantheonereportedin2003–
2007 for African descents living in the USA.
The growth curves of prostate cancer incidence rates ex-
pressed as ASRs during the period 1980–2005 (i.e., during
one generation), respectively, for Martinique, for the 11
metropolitan “department” registries and for overall metro-
politan France are displayed Figures 1 and 2. We found that
the overall growth rate of incidence in Martinique as wellProstate Cancer 3
Table 1: World age-standardized incidence rates (ASRs) of prostate cancer in 2005 in Caribbean, USA, UK, Sweden, metropolitan France,
and Martinique. Comparison with percentages of African descents, life expectancy at birth, dietary energy and fat supply, and dietary energy
and fat consumption.
Region
ASR 2005
speciﬁc
registriesa
ASR
Globocan
2008b
African
descentsc
(%)
LEBd
(years) DES (kcals)e FS
(g/person/day)f
DEC
(Cal/person/day)g
FC
(g/person/day)h
Caribbean
Jamaica — 51.1 90.9 69 2 558 68 2 808 84
Cuba 29.8 53.8 11 78 3 129 83 3 275 54
Dominican
Republic — 68.8 84 66 2 310 60 2 298 77
Haiti — 78.4 95 59 2 006 38 1 835 31
Bahamas — 78.5 85 71 2 776 91 2 690 93
Trinidad and
Tobago — 89.4 39.5 66 2 770 71 2 759 77
Guadeloupe — 94.8 90 76 2 776 84 — —
Puerto Rico — 102.2 —— — — — —
Barbados — 140 80 72 3 217 111 2 926 88
USA total 106 83.8 12.6 75 3 642 154 3 826 164
Black 164.8 — — — — —
White 101.8 — — — — —
UK 52.2i 62.1 2 77 3 270 142 3 426 137
Sweden 112.4 114.2 1.1 79 2 977 127 3 120 123
metropolitan
France 121.2 118.3 N/A 77 3 593 168 3 602 164
Martinique 177 173.7 80 76.5 2 768 84 ——
aAge-standardized rates (ASR) are per 100 000 man-year and are age-adjusted to the IARC world standard population. Data source are obtained for Cuba
from the Public Health Ministry [11], for USA, from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) 2003–2007 [16], for
UK, from the Information Services Division [12], Scotland [13] (see i), for Sweden, from the National Board of Health and Welfare [15], for metropolitan
France, from the French National Sanitary Surveillance Institute (InVS) [9], and for Martinique, from AMREC [8].
bData source for World ASR obtained from Globocan 2008 [10].
cData source obtained from the Encyclopedia of the Nations [17], the Befolkningsstatistik [19], and the Oﬃce by National Statistics [18], for the Caribbean
area, Sweden, and UK, respectively. The Caribbean people living in UK represent 1% of the overall population. For France, data are not available (N/A) for
ethical considerations and legal regulation. Values are also supposed to be low, within the same range as what is estimated for Sweden and UK.
dLife expectancy at birth (LEB) (males). Data source obtained from the WHO Core Health Indicators for 2006 (WHO World health statistics, 2008).
eDietary energy supply (DES), average total kilocalories available per person per day for the period 1988–1990. Data source obtained from FAO food balance
sheets. National indices of dietary fat supplies [18, 22].
fFat supplies (FS) are expressed as average grams of fat available per person per day for the period 1988–1990. Data source obtained from FAO food balance
sheets. National indices of dietary fat supplies [18, 22].
gDietary energy consumption (DEC) (Cal/person/day) for the period 2003–2005. Data source obtained from FAO Statistical Yearbook 2009 [19, 23].
hFat consumption (FC) (g/person/day) for the period 2003–2005. Data source obtained from FAO Statistical Yearbook 2009 [19, 23].
iASR 2005 determined from speciﬁc registries for the whole UK are not available. World ASR are 61.6 for England in 2002 and 52.2 for Scotland in 2005.
Europe-ASR for England, Wales and Scotland in 2005 are 95.6, 112.9 and 79.6, respectively.
as in metropolitan France is constant. Evaluation of the cor-
relation between incidence ASRs and time conﬁrmed indeed
that both incidence growth curves ﬁt in well an exponential
function: mean r = 0.993 for Martinique and mean r =
0.990 for metropolitan France, with incidence growth curve
equations in the form of y = 2E − 53e0.063x and of y = 6E −
50e0.0589x for Martinique and metropolitan France, respec-
tively.Nosigniﬁcantdiﬀerencecouldbedetectedintheinter-
action of time by incidence rates for Martinique compared
to metropolitan France (F1,18.2 = 0.68, P = 0.4 ). In other
words, after log transformation, when compared to metro-
politan France the overall growth rate of incidence of pro-
state cancer for Martinique is not signiﬁcantly diﬀerent
(β =− 0.004, P = 0.4, 95%, CI − 0.013 to 0.006). However,
as displayed in Figure 2, the incidence rates for Martinique
are signiﬁcantly at a constant higher level than those for
metropolitan France (0.416, P<0.001 , 95% CI 0.294 to
0.539). Table 1 also indicates that life expectancy at birth in
Martinique and Guadeloupe is similar to that in France, UK,
Sweden, and USA. By contrast, with the exception of Cuba,
life expectancy at birth in the Caribbean islands other than
Martinique and Guadeloupe is generally lower, in the range
of 59 to 72 years of age. We found no correlation between
prostate cancer incidence rates and life expectancy at birth
(r = 0.239, P = 0.4), and similarly, as far as diet westerni-
zation is concerned, no correlation between prostate cancer4 Prostate Cancer
Table 2: Amounts of pesticides used in Martinique (in tons) in
comparison with metropolitan France and other countries. Search
for a correlation with the incidence rates of prostate cancer.
Region Total
amounta,b Populationb Amount per
inhabitant ASR 2005c
Cuba 1 900 11 477 459 1·10−4 29.8
Sweden 1 553 9 074 055 1·10−4 112.4
UK 15 248 62 348 447 2·10−4 52.2
metropolitan
France 89 084 63 136 180 1.4·10−3 121.2
USA 555 300 310 232 863 1.7·10−3 106
Martinique 2 500 414 516 6·10−3 177
aAmounts are expressed in tons.
bValues are indicated for 2000.
cData from speciﬁc registries. See Table 1
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Figure 1: Evolution of prostate cancer incidence rates expressed as
ASRs in Martinique  in comparison with the incidence growth
curve obtained from the 11 “department” registries of metropolitan
France • and with the extrapolated overall incidence growth curve
for metropolitan France . Values of R2 were 0.9742 for Martinique
and 0.9845 for the 11 metropolitan “department” registries. Note
that for Martinique and metropolitan France, despite the fact they
are seemingly diverging since 1985, after log transformation, the 2
curves are not signiﬁcantly diverging (see Figure 2).
incidence rates as determined by Globocan 2008 and dietary
energy (expressed in calories) and fat consumption as deter-
minedbyFAO(forcalories:r = 0.235,P = 0.4,forlipids:r =
0.4, P = 0.1). However, when analyzing the pool of all coun-
tries or territories included in the study (see Table 1), we
found a strong correlation between life expectancy and die-
tary energy and fat intake (r = 0.911, P = 0.001). Moreover,
as suggested in Table 2, except for Sweden for which factors
other than pesticides should be considered, we found some
degree of correlation between the incidence rate of prostate
cancer and the level of pesticide use in the diﬀerent countries
and territories analyzed, the higher the level is, the higher the
prostate cancer incidence tends to be (R2 = 0.67, P = 0.04).
4. Discussion
Despite the fact that prostate cancer is the most frequent
diagnosed cancer and the second cause of cancer death in
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Figure 2: Evolution of Log transformed prostate cancer incidence
rates expressed as ASRs for Martinique and metropolitan France.
IncidenceratesinMartiniquearecontinuouslyatahigherlevelthan
in metropolitan France (P<0.001).
men in Western countries, its aetiology remains unclear. The
onlyestablishedriskfactorsareadvancingage,familyhistory,
and ethnic origin [26]. However, risk factors are not necess-
arily cancer causing agents, that is, agents directly involved in
the carcinogenesis process, but most often familial factors
thatcontributetogeneticsusceptibilityand/orlifestyle-relat-
ed factors that contribute to exposure to carcinogens and/or
cocarcinogens [27]. Moreover, although environmental cau-
ses of prostate carcinogenesis have not yet been clearly esta-
blished [26, 28], prostate cancer, as other cancers, is believed
to result from a multifactorial process involving both genetic
and environmental components [29, 30].
A major ﬁnding in the present study is that in Martini-
que, the incidence rate of prostate cancer is presently one of
the highest reported worldwide (e.g., even higher than the
one for the black people living in USA) and that it is contin-
uously growing since 1985 in an exponential mode, at a
growth rate not diﬀering from that of metropolitan France
(i.e.,theinitialdiﬀerenceremainsconstant)butthatitiscon-
stantly at a higher level that diﬀers signiﬁcantly from that of
metropolitan France, meaning that after log transformation,
the two incidence growth curves are parallel. A similar trend
inthecontinuouslygrowingincidencerateofprostatecancer
is reported in several countries in Europe, including Den-
mark, Finland, Norway, Sweden, Ireland, and The Nether-
lands [10, 31]. However, this trend is not observed in the
USA, since after the prostate cancer incidence rate peaked in
1992, there is in this country for still undetermined reasons a
decrease in prostate cancer incidence although the incidence
ratein2007remainsatahigherlevelthanitwasin1975[32].
In response to a recent published study carried out in
the USA concerning prostate cancer diagnosis and treatment
after the introduction of PSA screening [3], we have already
discussed the fact that the introduction two decades ago of
PSA-based screening techniques cannot explain the persist-
ing growing incidence of prostate cancer in many developed
countries [4]. Indeed, exponentially growing incidence rates,
such as those reported in Figures 1 and 2 with no visible in-
ﬂexion,tendtoconﬁrmourprevioushypothesisaccordingto
which, in addition to screening, other factors should be con-
sidered, accounting for the continuously growing incidenceProstate Cancer 5
Table 3: CMR and presumed CMR pesticides used in Martinique.
On the
market
Maximum of
use
Withdrawal from the
market for agricultural use
Continuation
of use
IARC
classiﬁcation
Technical DDT 1939 1960–1990 1972 — 2B
Technical
HCH 1940a 1950–1960 1988 1998 2B
Lindane 1940a 1950–1960 1992 — 2B
Aldrin/dieldrin 1950a 1960 1972 1992 3b
Chlordecone 1972 1980 1990 1993 2B
Chlordanes 1960a ——— 2 B
Simazine 1991a — 2001 — 3b
a:O ﬃcial data not available b: Aldrin, Dieldrin, and Simazine although presently classiﬁed category 3 by IARC have been shown to be associated with an
increased risk of prostate cancer (see text). Technical DDT is a mixture of the isomers p,p -DDT (85%), o,p -DDT (15%) and o,o -DDT (<1%) and technical
HCH, a mixture of the isomers α, β,a n dγ. Chlordanes include trans-chlordane, cis-chlordane, trans-nonachlor, cis-nonachlor, and heptachlor.
[4]. Moreover, it has been clearly shown in several Euro-
peancountriesthattheriseinprostatecancerincidencestart-
ed long before the initial use of PSA screening test [2, 32].
Unfortunately, there is no available data comparing the rate
ofuseofPSAscreeningtestperinhabitantinMartiniqueand
metropolitan France. However, the health care system in
Martinique is rigorously the same as it is in metropolitan
France as far as organization, health expenditure, and train-
ing of physicians are concerned [20] and the date of PSA
screening technique introduction has been identical in both
cases. Consequently, it is unlikely that the signiﬁcantly diﬀe-
rent higher level of incidence rates observed in Martinique
might be due to a diﬀerence in screening. Indeed, if we sup-
pose that during our study observation period, the incidence
of prostate cancer observed in Martinique, which is situated
far away from metropolitan France, would have been asso-
ciated with a less frequent use of PSA test, the results would
have been exactly the opposite of what we observed, that is,
alowerrateofprostatecancerincidence.Inversely,forsimilar
reasons, it would be not meaningful to speculate that a less
frequent use of PSA test would account for the lower inci-
dence rate of prostate cancer observed in metropolitan
France, since the PSA test has been initially developed in this
country.
Similarly, life expectancy at birth of the population in
Martinique does not diﬀer from the one in metropolitan
France (Table 1), conﬁrming that quality of health care sys-
tem, socioeconomic status, and lifestyle-related behaviour of
people living in Martinique and metropolitan France cannot
per se account for the observed diﬀerence in incidence.
Therefore, this led us to look for other parameters which
couldaccountforthehigherincidencerateofprostatecancer
in Martinique as compared to metropolitan France.
As observed in USA, men of African descents when com-
pared to Caucasians have been shown to be associated with
an ethnographic genetic factor making them more suscepti-
bletoprostatecarcinogenesiswhiletheybotharelivinginthe
same environment [33]. Therefore, the diﬀerence in inciden-
ce rates between Martinique and metropolitan France could
be explained from a genetic perspective by the African origin
of Caribbean population [34]. Considering the incidence
growth curve in Martinique is constantly at a signiﬁcantly
higher level than it is in metropolitan France, and that after
log transformation this growth curve is parallel to that of
metropolitan France (see Figures 1 and 2), this strongly sug-
gests that not only a Caribbean African descent-associated
genetic susceptibility factor is involved in prostate carcino-
genesis in Martinique, as it is the case for American African
descents living in the USA [35], but also that this factor re-
mained constant during the one generation observation per-
iod (1980–2005). However, the localenvironment in Martin-
ique and metropolitan France is quite diﬀerent. As indicated
in Table 1, albeit they are genetically close if not equivalent to
that of Martinique and living in similar regional areas Carib-
bean populations appear generally to have much lower pros-
tate cancer incidence rates. This suggests that in addition to
the ethnographic genetic factor,a nongenetic factor or rather
a strong interaction between genetic and environmental fac-
tors may be involved in countries or territories with high
rates of prostate cancer incidence. However, values of pros-
tate cancer incidence in Caribbean countries or territories
where there is no available speciﬁc cancer incidence registry
may be underestimated, because uptake of PSA testing might
be lower, as it may be the case in USA for black men in com-
parison to with Caucasians [36]. As discussed above, a diﬀe-
rence in PSA screening use between Martinique and metro-
politan France is unlikely. Furthermore, as reported in
Table 1, Cuba for which a speciﬁc cancer incidence regi-
stry does exist is associated with a signiﬁcant lower prostate
cancer incidence rate than in the USA despite the fact
thereisasimilarpercentageofAfricandescentsinbothcoun-
tries. Yet, a similar discrepancy does exist when comparing
the prostate cancer incidence rate in Sweden to that in UK,
while these countries, which both have similar high level
health care systems and excellent speciﬁc cancer incidence
registries, have a similar percentage of African descents
(Table 1). With regards to Martinique and metropolitan
France, it would have been instructive to know the inciden-
ce rate of prostate cancer in the Caucasian population in
Martinique.Unfortunately,suchdataarenotavailable.Asre-
ported by IARC in the Globocan 2008 database, the dis-
crepancy between the incidence rates in Martinique and6 Prostate Cancer
Guadeloupe should be noted considering that the popula-
tion and local environment are seemingly similar if not
identical. Therefore, it appears that an environmental factor
speciﬁc to Martinique could be responsible for the higher
elevated prostate cancer incidence rate in this island.
On the basis of epidemiological studies, an increase in
prostate cancer incidence in people migrating from low can-
cer incidence countries to high incidence ones [35, 37, 38]
has been observed, suggesting that lifestyle-related and/or
environmental factors could be potential risk factors for pro-
state cancer [39, 40]. However, the carcinogenic role of so-
called westernized dietary regimens which mainly consists of
a low intake of antioxidants still remains unclear. The asso-
ciation of prostate cancer risk with dietary factors such as
high intake of fat, meat, and dairy products has been consid-
ered[35,41],but several epidemiological studies have shown
conﬂicting negative results [35, 42]. On the basis of our anal-
ysis of international available data, we found that life expec-
tancyatbirthwasstronglycorrelatedwithdietaryenergyand
fat supply or consumption, whereas we could not ﬁnd any
correlation between prostate cancer incidence and dietary
energy and fat supply or consumption. For example, despite
the fact that during the period 1988–1990, Cuba, was believ-
ed to have one of the highest level of daily calories per person
intheCaribbean,asindicatedinTable 1,prostatecancerinci-
dence is the lowest, whereas albeit Martinique had the lowest
level of daily calories per person in comparison with the ones
in UK, Sweden, France, and USA, and for this reason is con-
sidered to be associated with a modest diet westernization
[43], prostate cancer incidence is the highest. A further argu-
ment suggesting a possible role of environmental causes in
the growing incidence of prostate cancer is that although UK
is associated with a high level of dietary energy and fat sup-
ply and consumption similar to that in USA, Sweden, and
France, prostate cancer incidence rate is one of the lowest of
Western countries, as it is the case for Cuba (Table 1). And
this is particularly true for men of African or Caribbean ori-
gin living in UK, since for this speciﬁc population, prostate
cancer incidence rate is 70% less than the corresponding one
forAfricandescentslivinginUSA[34].Moreover,ithasbeen
shown in the European prospective investigation into cancer
and nutrition (EPIC) study that fruits and vegetables do not
protect against prostate cancer [44]. These data therefore
strongly support the concept that risk factors other than
those related to lifestyle are associated with prostate cancer
occurrence, that dietary antioxidants do not play a protective
role against prostate cancer, and consequently that mech-
anisms other than free radicals production are involved in
prostate carcinogenesis [30].
Lifetime exposure to endogenous androgens and estro-
gens has been suggested to be a risk factor for prostate cancer
[45,46],butthisendogenousmodeldoesnotﬁtintheresults
of the present study showing a continued increase of cancer
incidence since 1985.
We have previously distinguished lifestyle-related risk
factorsfromenvironmentalcancer-causingagentsanddeﬁn-
ed the latter as exogenous physical, chemical, and biological
carcinogens or cocarcinogens [2, 4, 47].
AsshowninFigures1and2,althoughsigniﬁcantlydiﬀer-
ing in levels, the two incidence rate growth curves follow a
similar exponential pattern. This may reﬂect a similar over-
alleﬀectofdiﬀerentenvironmentalfactors,intheframework
of gene-environment interactions, whatever these factors
could be. In many developed countries including metropoli-
tan France, such factors are unknown. The lack of major in-
dustries and associated sources of industrial pollution in
Martinique suggests that a factor linked to agriculture may
be involved, considering that agriculture is the main econo-
mic activity of the island. As indicated in Table 3,s e v e r a l
carcinogenic, mutagenic, and/or reprotoxic (CMR) or pre-
sumed CMR pesticides including dichloro-diphenyl-tri-
chloroethane (DDT), hexachlorocyclohexane (HCH), chlor-
danes, aldrin, dieldrin, chlordecone, and simazine have been
used in great quantities since 1950 in Martinique for the pre-
ventivetreatmentofbananaplantations.Wehaveshownthat
several of these pesticides used between 1950 and 1970 in
Martinique have been detected at considerably high levels in
the adipose tissue of all subjects tested [7]. In Martinique, as
it is the case for prostate cancer, there is also a recently grow-
ing incidence of breast carcinoma [8] ,a n dw eh a v ep r o p o s e d
that organochlorine pesticides alone or through cocktail
eﬀects could cause both prostate and breast cancers by act-
ing through similar common endocrine disruption mech-
anisms [48]. Many epidemiological studies—but not all—
have reported that exposure to organochlorine pesticides is
associated with an increased risk of prostate cancer and that
among the diﬀerent pesticides which have been used inten-
sively since 1950 in Martinique, DDT and 1,1-dichloro-2,2 -
bis-p-chlorophenyl-ethylene (DDE) [49, 50], Lindane [51],
aldrin and dieldrin [49], chlordane [49], heptachlor [49, 51],
oxychlordane [52, 53], and the nonorganochlorinated pesti-
cide simazine [53] are associated with a signiﬁcantly increas-
ed risk of prostate cancer and/or are detected at signiﬁcantly
higher levels in prostate cancer patients than in controls.
Also, more recently, a case-control study carried out in
Guadeloupe has revealed that exposure to chlordecone, an
organochlorine pesticide with strong oestrogenic properties
usedbothinMartiniqueandGuadeloupe,isassociatedsigni-
ﬁcantly with an increased prostate cancer risk [54]. But this
study does not prove that chlordecone, is the cause of the
continuousgrowingincidenceofprostatecancerinthesetwo
islands. Other factors including the use of other pesticide
t y p e sm a yb ei n v o l v e d .A ss u g g e s t e di nTable 2,e x c e p tf o r
Sweden, for which factors other than pesticides are probably
involved,theamountofpesticidesusedexpressedperinhabi-
tantappearstobemorethanfourtimeshigherinMartinique
than what it is in metropolitan France, and there seems to
be a statistically signiﬁcant positive correlation between the
incidence rates of prostate cancer and the levels of exposure
to pesticides in the diﬀerent countries analyzed, suggesting
that among the environmental factors causally involved in
prostate carcinogenesis the intensive use of pesticides could
be implicated.
In conclusion, we suggest that the high incidence rate of
prostate cancer in Martinique may, in fact, be the result of
gene-environment interactions in highly genetically suscep-
tible African descent individuals, that environmental factorsProstate Cancer 7
may account for the continued increase of incidence of this
cancer, and that among these factors, CMR or presumed
CMR organochlorine pesticides may play a role. Further in-
vestigations are, however, needed to determine precisely
which causative factors are actually speciﬁcally involved.
Abbreviations
ASR: Age-standardized rate
CI: Conﬁdence intervals
CMR: Carcinogenic, mutagenic, and/or
reprotoxic
DDE: 1,1-dichloro-2,2
 -bis-p-chlorophenyl-
ethylene
DDT: Dichloro-diphenyl-trichloroethane
DEC: Dietary energy consumption
DES: Dietary energy supply
EPIC: European prospective investigation
into cancer and nutrition
FC: Fat consumption
HCH: Hexachlorocyclohexane
IARC: International Agency for Research on
Cancer
InVS: French National Sanitary Surveillance
Institute
LEB: Life expectancy at birth
PSA: Prostate-speciﬁc antigen
REML: Restricted maximum likelihood
SEER: Surveillance, epidemiology, and end
results.
Acknowledgments
This work was supported by a speciﬁc grant from ARTAC
provided by patient’s donations and grants from Lea Nature-
France,f r o mOeuvre d’Assistante Fraternelle and from Fonda-
tion pour la promotion de l’homme. The authors thank Fred-
eric Campion (Sweden) for having done the mathematical
and statistical analysis of data, Laurent Schwartz (France) for
having given general scientiﬁc advice, John A. Newby (UK)
for having supplied recent epidemiological data for UK, and
Tony Tweedale (UK) for having reviewed the paper.
References
[1] B.F.Hankey, E.J.Feuer, L.X.Cleggetal.,“Cancer surveillance
series: interpreting trends in prostate cancer—Part I: evidence
of the eﬀects of screening in recent prostate cancer incidence,
mortality, and survival rates,” Journal of the National Cancer
Institute, vol. 91, no. 12, pp. 1017–1024, 1999.
[2] D. Belpomme, P. Irigaray, A. J. Sasco et al., “The growing inci-
dence of cancer: role of lifestyle and screening detection (Re-
view),” International Journal of Oncology,v o l .3 0 ,n o .5 ,p p .
1037–1049, 2007.
[ 3 ]H .G .W e l c ha n dP .C .A l b e r t s e n ,“ P r o s t a t ec a n c e rd i a g n o s i s
and treatment after the introduction of prostate-speciﬁc anti-
gen screening: 1986–2005,” Journal of the National Cancer In-
stitute, vol. 101, no. 19, pp. 1325–1329, 2009.
[4] D. Belpomme and P. Irigaray, “Re: prostate cancer diagnosis
and treatment after the introduction of prostate-speciﬁc anti-
gen screening: 1986–2005,” Journal of the National Cancer In-
stitute, vol. 102, no. 7, pp. 506–507, 2010.
[5] P. Irigaray, J. A. Newby, R. Clapp et al., “Lifestyle-related fac-
tors and environmental agents causing cancer: an overview,”
Biomedicine and Pharmacotherapy, vol. 61, no. 10, pp. 640–
658, 2007.
[ 6 ]J .A .N e w b y ,C .C .B u s b y ,C .V .H o w a r d ,a n dM .J .P l a t t ,“ T h e
cancer incidence temporality index: an index to show tempor-
al changes in the age of onset of overall and speciﬁc cancer
(England and Wales, 1971–1999),” Biomedicine and Pharma-
cotherapy, vol. 61, no. 10, pp. 623–630, 2007.
[7] D. Belpomme, P. Irigaray, M. Ossondo, D. Vacque, and M.
Martin, “Prostate cancer as an environmental disease: an eco-
logical study in the French Caribbean islands, Martinique and
Guadeloupe,” International Journal of Oncology, vol. 34, no. 4,
pp. 1037–1044, 2009.
[8] AMREC Le Cancer en Martinique de 2001 ` a 2005, Monogra-
phie du Registre des Cancers de la Martinique, 2010.
[9] A. Belot, P. Grosclaude, N. Bossard et al., “Cancer incidence
and mortality in France over the period 1980–2005,” Revue
d’Epidemiologie et de Sante Publique, vol. 56, no. 3, pp. 159–
175, 2008.
[10] J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, and D.
M. Parkin, GLOBOCAN 2008, Cancer Incidence and Mortal-
ity Worldwide, International Agency for Research on Cancer,
Lyon, France, 2010, IARC CancerBase no. 10, http://globocan.
iarc.fr/.
[11] Anuario Estadistico De Salud 2009, “N´ umero 38 del Anuario
Estad´ ıstico de Salud con informaci´ on actualizada hasta el a˜ no
2009,” Ministerio De Salud Publica, Direccion Nacional De
registros Medicos Y Estadisticas De Salud, http://ﬁles.sld.cu/
dne/ﬁles/2010/04/anuario-2009e3.pdf.
[12] OﬃceforNationalStatistics,England,http://www.ons.gov.uk/
ons/index.html.
[13] InformationServicesDivision,Scotland,ISDCancerInforma-
tion Programme, http://www.isdscotland.org/Health-Topics/
Cancer/Cancer-Statistics/Male-Genital-Organs/#prostate.
[14] Welsh Cancer Intelligence and Surveillance Unit, Cancer In-
cidence in Wales, 2003–2007, http://www.wales.nhs.uk/sites3/
Documents/242/Cancer%20Incidence%20in%20Wales%20
2003-2007.pdf.
[15] National Board of Health and Welfare. Centre for Epidemi-
ology, Statistics—Health and Diseases. Cancer Incidence in
Sweden 2005, http://www.socialstyrelsen.se/Lists/Artikelkata-
log/Attachments/9329/2007-42-3 2007423.pdf.
[16] Surveillance, Epidemiology, and End Results (SEER) Program
of the National Cancer Institute (NCI), http://seer.cancer.gov/
csr/1975 2007/results merged/sect 23 prostate.pdf.
[17] The Encyclopedia of the Nations, http://www.nationsencyclo-
pedia.com/index.html.
[18] Oﬃce by National Statistics, The UK population: by ethnic
group, Census, April 2001.
[19] “Befolkningsstatistik 2000, del 3,” Stockholm: Statistiska Cen-
tralbyran,Statistics Sweden, 2001.
[20] P. Bazely and C. Catteau, “Direction de la recherch´ e, des ´ etud-
es, de l’´ evaluation et des statistiques DREES. Etat de sant´ e,”
oﬀre de soins dans les d´ epartements d’Outre-mer, Guade-
loupe, Guyane, Martinique, R´ eunion no.14, juin 2001.
[21] WHO World Health Statistics, “ WHO Core Health Indi-
cators database,” 2008, http://apps.who.int/whosis/database/
core/core select.cfm?strISO3 select=ALL&strIndicator select
=ALL&intYear select=latest&language=english.
[22] FAOFoodBalance Sheets,“National indicesofdietaryfatsup-
plies.Countriesrankedfatenergyratioofnationalfoodsupply8 Prostate Cancer
1988–1990Fatsandoilsinhumannutrition,”ReportofaJoint
Expert Consultation Organized by the Food and Agriculture
Organization of the United Nations and the World Health
Organization Rome, FAO, Rome, Italy, October 1993.
[23] FAOSTAT, “FAO Statistical Yearbook 2009,” The Statistics Di-
vision FAO 2009, http://faostat.fao.org/site/368/default.aspx
#ancor.
[24] Eurostat Statistical Books, “The use of plant protection pro-
ducts in the European Union. Dtat 1992–2003,” 2007,
http://epp.eurostat.ec.europa.eu/cache/ITY OFFPUB/KS-76-
06-669/EN/KS-76-06-669-EN.PDF.
[25] US-EPA, “2000-2001 Pesticide Market Estimates: Historical
Data,” http://www.epa.gov/opp00001/pestsales/01pestsales/
historical data2001 3.htm.
[26] H. Gr¨ onberg, “Prostate cancer epidemiology,” The Lancet, vol.
361, no. 9360, pp. 859–864, 2003.
[27] D. Belpomme, “Cancer and the environment: facts, ﬁgures,
methods and misinterpretations,” Biomedicine and Pharmaco-
therapy, vol. 61, no. 10, pp. 611–613, 2007.
[28] W .G.N elson,A.M.DeMarzo ,andW .B.Isaacs,“Prostatecan-
cer,” New England Journal of Medicine, vol. 349, no. 4, pp. 366–
381, 2003.
[29] D. J. Schaid, “The complex genetic epidemiology of prostate
cancer,” Human Molecular Genetics, vol. 13, no. 1, pp. R103–
R121, 2004.
[30] P. Irigaray and D. Belpomme, “Basic properties and molecular
mechanisms of exogenous chemical carcinogens,” Carcinogen-
esis, vol. 31, no. 2, pp. 135–148, 2010.
[31] R. Kv˚ ale, A. Auvinen, H. O. Adami et al., “Interpreting trends
in prostate cancer incidence and mortality in the ﬁve Nordic
countries,” Journal of the National Cancer Institute, vol. 99, no.
24, pp. 1881–1887, 2007.
[32] S. F. Altekruse, C. L. Kosary, M. Krapcho et al., Eds., “SEER
Cancer Statistics Review, 1975–2007,” National Cancer Instit-
ute, Bethesda, Md, USA, November 2009, http://seer.cancer.
gov/csr/1975 2007/.
[33] S. J. Freedland and W. B. Isaacs, “Explaining racial diﬀerences
in prostate cancer in the United States: sociology or biology?”
Prostate, vol. 62, no. 3, pp. 243–252, 2005.
[34] Y. Ben-Shlomo, S. Evans, F. Ibrahim et al., “The Risk of Pro-
state Cancer amongst Black Men in the United Kingdom: the
PROCESS Cohort Study,” European Urology,v o l .5 3 ,n o .1 ,p p .
99–105, 2008.
[35] A.S.Whittemore,L.N.Kolonel,A.H.Wuetal.,“Prostatecan-
cerinrelationtodiet,physicalactivity,andbodysizeinblacks,
whites,andAsiansintheUnitedStatesandCanada,”Journalof
the National Cancer Institute, vol. 87, no. 9, pp. 652–661, 1995.
[36] R. Etzioni, K. M. Berry, J. M. Legler, and P. Shaw, “Prostate-
speciﬁc antigen testing in black and white men: an analysis of
medicare claims from 1991–1998,” Urology, vol. 59, no. 2, pp.
251–255, 2002.
[37] F.F.Angwofo,“Migrationandprostatecancer:aninternation-
alperspective,”JournaloftheNationalMedicalAssociation,vol.
90, pp. S720–S723, 1998.
[38] L. S. Cook, M. Goldoft, S. M. Schwartz, and N. S. Weiss, “Inci-
dence of adenocarcinoma of the prostate in Asian immigrants
to the United States and their descendants,” Journal of Urology,
vol. 161, no. 1, pp. 152–155, 1999.
[39] L. N. Kolonel, “Fat, meat, and prostate cancer,” Epidemiologic
Reviews, vol. 23, no. 1, pp. 72–81, 2001.
[40] T. Shirai, M. Asamoto, S. Takahashi, and K. Imaida, “Diet and
prostate cancer,” Toxicology, vol. 181-182, pp. 89–94, 2002.
[41] E.Giovannucci,E.B.Rimm,G.A.Colditzetal.,“Aprospective
study of dietary fat and risk of prostate cancer,” Journal of the
National Cancer Institute, vol. 85, no. 19, pp. 1571–1579, 1993.
[42] M. M. Lee, R. T. Wang, A. W. Hsing, F. L. Gu, T. Wang, and M.
Spitz, “Case-control study of diet and prostate cancer in
China,” Cancer Causes and Control, vol. 9, no. 6, pp. 545–552,
1998.
[43] C. Dubuisson, F. H´ eraud, J. C. Leblanc et al., “Impact of sub-
sistence production on the management options to reduce the
food exposure of the Martinican population to Chlordecone,”
Regulatory Toxicology and Pharmacology, vol. 49, no. 1, pp. 5–
16, 2007.
[44] T. J. Key, N. Allen, P. Appleby et al., “Fruits and vegetables and
prostate cancer: no association among 1,104 cases in a pro-
spective study of 130,544 men in the European Prospective In-
vestigation into Cancer and Nutrition (EPIC),” International
Journal of Cancer, vol. 109, no. 1, pp. 119–124, 2004.
[45] M. C. Bosland, “The role of steroid hormones in prostate car-
cinogenesis,” Journal of the National Cancer Institute, no. 27,
pp. 39–66, 2000.
[46] F.Modugno,J.L.Weissfeld,D.L.Trumpetal.,“Allelicvariants
ofaromataseandtheandrogen andestrogen receptors:toward
a multigenic model of prostate cancer risk,” Clinical Cancer
Research, vol. 7, no. 10, pp. 3092–3096, 2001.
[47] D.Belpomme,P.Irigaray,L.Hardelletal.,“Themultitudeand
diversity of environmental carcinogens,” Environmental Re-
search, vol. 105, no. 3, pp. 414–429, 2007.
[48] M. Landau-Ossondo, N. Rabia, J. Jos-Pelage et al., “Why pesti-
cides could be a common cause of prostate and breast cancers
in the French Caribbean Island, Martinique. An overview on
key mechanisms of pesticide-induced cancer,” Biomedicine
and Pharmacotherapy, vol. 63, no. 6, pp. 383–395, 2009.
[49] M. C. R. Alavanja, C. Samanic, M. Dosemeci et al., “Use of
agricultural pesticides and prostate cancer risk in the agricul-
tural health study cohort,” American Journal of Epidemiology,
vol. 157, no. 9, pp. 800–814, 2003.
[50] L. Settimi, A. Masina, A. Andrion, and O. Axelson, “Prostate
cancer and exposure to pesticides in agricultural settings,” In-
ternational Journal of Cancer, vol. 104, no. 4, pp. 458–461,
2003.
[51] P.K.MillsandR.Yang,“ProstatecancerriskinCaliforniafarm
workers,” Journal of Occupational and Environmental Medi-
cine, vol. 45, no. 3, pp. 249–258, 2003.
[52] J. M. Ritchie, S. L. Vial, L. J. Fuortes, H. Guo, V. E. Reedy, and
E. M. Smith, “Organochlorines and risk of prostate cancer,”
Journal of Occupational and Environmental Medicine, vol. 45,
no. 7, pp. 692–702, 2003.
[53] L. Hardell, S. O. Andersson, M. Carlberg et al., “Adipose tissue
concentrations of persistent organic pollutants and the risk of
prostate cancer,” Journal of Occupational and Environmental
Medicine, vol. 48, no. 7, pp. 700–707, 2006.
[54] L. Multigner, J. R. Ndong, A. Giusti et al., “Chlordecone ex-
posure and risk of prostate cancer,” Journal of Clinical Onco-
logy, vol. 28, no. 21, pp. 3457–3462, 2010.